Effect of Prenatal Docosahexaenoic Acid Supplementation on Blood Pressure in Children With Overweight Condition or Obesity: A Secondary Analysis of a Randomized Clinical Trial.

ABSTRACT:

Importance

The blood pressure-lowering property of docosahexaenoic acid (DHA) in children and adults is known, and an observational study from the Netherlands has linked higher intrauterine DHA exposure to lower childhood blood pressure. However, the association of prenatal intake of DHA supplement with childhood blood pressure has not been evaluated in randomized clinical trials.

Objective

To determine the effect of DHA supplementation during pregnancy on childhood blood pressure.

Design, setting, and participants

This prespecified secondary analysis of the Kansas University DHA Outcome Study (KUDOS), a phase 3, double-blind, randomized, placebo-controlled clinical trial was conducted at several local hospitals in the Kansas City, Kansas, metropolitan area. Pregnant

SUBMITTER: Kerling EH 

PROVIDER: S-EPMC6484605 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature